Description
Dabigatran Etexilate Mesylate is a generic prescription oral capsule medication, available in strengths of 75mg, 110mg, and 150mg (equivalent to base). Manufactured by Alembic Pharmaceuticals, it acts as a direct thrombin inhibitor to help prevent blood clots. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Dabigatran etexilate | HTML | Access the FDA dataset for Dabigatran etexilate — ANDA 214358 submitted by Mylan Institutional LLC | Open resource |